Govt Approves Sinovac Jabs 'in The Public Interest'
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1576185_1_20210218193250.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1576185-20210218.htm', 'DCS.dcsqry', '' ); } } }); }); });
2021-02-18 HKT 12:16
Share this story
The government on Thursday approved the use of a Covid-19 vaccine made by mainland firm Sinovac, describing it as a necessary move and one that is in the public interest.
Experts advising the SAR authorities on coronavirus vaccines said earlier this week that with a reported efficacy rate of 62.3 percent, the protection offered by the Sinovac jabs would outweigh any risks.
A million doses of the vaccine are expected to arrive in Hong Kong on Friday, with doctors anticipating that the vaccination programme could be rolled out as soon as next week.
A government statement said the secretary for health considered it necessary to approve the Sinovac jabs after considering the experts' opinion and the public health risks posed by the pandemic.
The statement said the government will complete the necessary quality checks after receiving the jabs, and will continue to ask Sinovac to provide it with the latest clinical data.
The SAR government eventually decided not to require the mainland company to publish clinical data in medical journals before its jabs could be approved here. The vaccine has so far not been approved by the World Health Organisation.
The Sinovac vaccine is the second approved for use in the SAR, after jabs made by German firm BioNTech were earlier given the green light.
ZA Bank Brings Nasdaq Data To Hong Kong, Expanding US Stock Access And Investor Education
ZA Bank and Nasdaq have announced a collaboration aimed at enhancing digital wealth management in Hong Kong and interna... Read more
Hong Kong To Study One‑Stop Infrastructure For Equities, Bonds And Digital Assets
The Hong Kong Monetary Authority’s (HKMA) CMU OmniClear and the Hong Kong Exchange (HKEX) are set to begin a study on... Read more
Hong Kong To Issue First Stablecoin Licenses In March, Expand Crypto Regulation
Hong Kong will issue its first licenses for fiat-referenced stablecoin issuers in March and introduce new legislation l... Read more
MSIG Joins US$6B IFC Credit Insurance Facility To Boost Emerging Market Lending
MSIG USA and Mitsui Sumitomo Insurance (MSI Japan), together referred to as MSIG, have joined a new insurance-ba... Read more
Why The $2 Trillion Stablecoin Prediction Is Too Low
McKinsey estimates the stablecoin market will hit $2 trillion by 2028. But according to Sam Lin, COO of dtcpay, even th... Read more
RedotPay Eyes US IPO With Potential US$1 Billion Raise
RedotPay is reportedly exploring an IPO in the US that could raise more than US$1 billion, according to people famili... Read more